Z E Davidson1, M M Ryan2, A J Kornberg2, K Sinclair3, A Cairns3, K Z Walker4, H Truby4. 1. 1] Department Nutrition and Dietetics, Monash University, Melbourne, Victoria, Australia [2] Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. 2. 1] Murdoch Childrens Research Institute, Melbourne, Victoria, Australia [2] Department of Neurology, The Royal Children's Hospital, Melbourne, Victoria, Australia. 3. Neurosciences Department, Royal Children's Hospital, Brisbane, Queensland, Australia. 4. Department Nutrition and Dietetics, Monash University, Melbourne, Victoria, Australia.
Abstract
BACKGROUND/ OBJECTIVES: Nutritional issues that are associated with Duchenne muscular dystrophy (DMD) remain poorly understood. The aim of this analysis was to describe and explore longitudinal observations of body mass index (BMI) in a cohort of children with DMD. SUBJECTS/ METHODS: Anthropometric and clinical characteristics were collected retrospectively and longitudinally for boys with DMD seen in two large neuromuscular clinics. BMI Z-scores were determined using the Centers for Disease Control and Prevention reference values for children (2000). RESULTS: Medical records (n=193) were examined from which 75% were included for analysis. The mean age of the cohort at the time of data collection was 11.9 years, with 72% of patients currently or previously using steroids. The highest prevalence of obesity based on the BMI Z-score was 50% at the age of 10 years. Longitudinally, BMI Z-scores from the age of 2 to 12 years plot approximately one s.d. above the mean, after which there is a marked and progressive decline. BMI gainers were identified for whom BMI Z-score increased by 1.65 units compared with the 0.09 units in non-gainers. BMI gainers were younger when they had their first BMI measurement (5.9 vs 7.2 years), and this measure was significantly lower compared with the non-gainers (BMI Z-score: 0.04 vs 1.17). In this cohort, BMI was associated with age, ambulatory status and lung function. CONCLUSIONS: This study demonstrates that boys with DMD using steroid therapy experience shifts in BMI. A declining BMI appears to be associated with increasing age. Interpretation of growth patterns is limited here by a lack of normative growth references in DMD.
BACKGROUND/ OBJECTIVES: Nutritional issues that are associated with Duchenne muscular dystrophy (DMD) remain poorly understood. The aim of this analysis was to describe and explore longitudinal observations of body mass index (BMI) in a cohort of children with DMD. SUBJECTS/ METHODS: Anthropometric and clinical characteristics were collected retrospectively and longitudinally for boys with DMD seen in two large neuromuscular clinics. BMI Z-scores were determined using the Centers for Disease Control and Prevention reference values for children (2000). RESULTS: Medical records (n=193) were examined from which 75% were included for analysis. The mean age of the cohort at the time of data collection was 11.9 years, with 72% of patients currently or previously using steroids. The highest prevalence of obesity based on the BMI Z-score was 50% at the age of 10 years. Longitudinally, BMI Z-scores from the age of 2 to 12 years plot approximately one s.d. above the mean, after which there is a marked and progressive decline. BMI gainers were identified for whom BMI Z-score increased by 1.65 units compared with the 0.09 units in non-gainers. BMI gainers were younger when they had their first BMI measurement (5.9 vs 7.2 years), and this measure was significantly lower compared with the non-gainers (BMI Z-score: 0.04 vs 1.17). In this cohort, BMI was associated with age, ambulatory status and lung function. CONCLUSIONS: This study demonstrates that boys with DMD using steroid therapy experience shifts in BMI. A declining BMI appears to be associated with increasing age. Interpretation of growth patterns is limited here by a lack of normative growth references in DMD.
Authors: R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson Journal: Adv Data Date: 2000-06-08
Authors: Maria Luisa Bianchi; Doug Biggar; Kate Bushby; Alan D Rogol; Meilan M Rutter; Brian Tseng Journal: Neuromuscul Disord Date: 2011-02-25 Impact factor: 4.296
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: Mattia Quattrocelli; Isabella M Salamone; Patrick G Page; James L Warner; Alexis R Demonbreun; Elizabeth M McNally Journal: Am J Pathol Date: 2017-08-18 Impact factor: 4.307
Authors: Gabrielle A Donlevy; Sarah P Garnett; Kayla M D Cornett; Marnee J McKay; Jennifer N Baldwin; Rosemary R Shy; Sabrina W Yum; Timothy Estilow; Isabella Moroni; Maria Foscan; Emanuela Pagliano; Davide Pareyson; Matilde Laura; Trupti Bhandari; Francesco Muntoni; Mary M Reilly; Richard S Finkel; Janet E Sowden; Katy J Eichinger; David N Herrmann; Michael E Shy; Joshua Burns; Manoj P Menezes Journal: Neurology Date: 2021-09-07 Impact factor: 9.910
Authors: Saskia L S Houwen-van Opstal; Lotte Heutinck; Merel Jansen; Yvonne D Krom; Edith H C Cup; Jos G M Hendriksen; Michel A A P Willemsen; Jan J G M Verschuuren; Erik H Niks; Imelda J M de Groot Journal: Muscle Nerve Date: 2021-09-09 Impact factor: 3.852
Authors: David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni Journal: J Neuromuscul Dis Date: 2018
Authors: Meghann McKane; Jonathan H Soslow; Meng Xu; Benjamin R Saville; James C Slaughter; W Bryan Burnette; Larry W Markham Journal: J Child Neurol Date: 2017-01-13 Impact factor: 1.987